| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
| Sales | 113 | 62 | 138 | 225 | 750 |
| Sales Growth | +82.80% | -55.17% | -38.58% | -70.01% | +148.03% |
| Net Income | -456 | -813 | -794 | -2,394 | -1,185 |
| Net Income Growth | +43.90% | -2.41% | +66.83% | -102.03% | -41.74% |
Ovation Science Inc (OVAT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Ovation Science Inc. is a Canada-based company mainly engaged in providing topical and transdermal cannabis products under the "Ovation" brand label. It utilizes the patented "Invisicare" delivery technology, which it acquired for exclusive use for cannabis-formulated products. The group has two geographical segments: Canada and the United States. Key revenue is generated from the United States.
Fiscal Year End Date: 12/31